Joseph J. Wolk - Feb 8, 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
/s/ Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
Stock symbol
JNJ
Transactions as of
Feb 8, 2024
Transactions value $
-$163,678
Form type
4
Date filed
2/12/2024, 07:25 PM
Previous filing
Aug 25, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +3.69K +7.34% $0.00 53.9K Feb 8, 2024 Direct F1
transaction JNJ Common Stock Tax liability -$164K -1.05K -1.94% $156.33 52.9K Feb 8, 2024 Direct F2, F3
holding JNJ Common Stock 2.05K Feb 8, 2024 By 401k F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -3.69K -100% $0.00* 0 Feb 8, 2024 Common Stock 3.69K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Reflects an adjustment to the total number of shares previously reported by the reporting person after a reconciliation of such person's ownership records.
F4 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).